Pharma & biotech
License or co-develop platform assets. We evaluate molecules that are delivered intravenously today, or not delivered transdermally at all, for controlled multi-day release.
Partners & investors
Build the next generation of transdermal delivery with us.
We are open to collaboration and investment. We work with partners across the transdermal value chain who share our view that continuous therapy deserves purpose-built delivery.
CDMOs & suppliers
We are building a repeatable, scalable global manufacturing architecture and work with transdermal CDMOs and materials suppliers.
Clinicians & researchers
Prescribers, menopause specialists and clinical investigators help shape product requirements and real-world evidence.
Investors
A US–Australian company with a sequenced plan: a capital-efficient Gen-1 product first, then a Gen-2 platform across prescription and consumer health.
Investors
We are open to investment and collaboration.
LORAI Health is a US–Australian company building a transdermal platform with a sequenced, capital-efficient plan: a Gen-1 estradiol patch to prove the system, then a Gen-2 platform across prescription and consumer health. We welcome conversations with investors and strategic partners who want to be part of it.
- US research and development at the Delaware Innovation Space (DISI)
- Experienced team across materials science, regulatory and women’s health
- Active CDMO and supplier engagement for Gen-1
Contact
Start a conversation
Tell us who you are and what you are working on.
United States
LORAI Health LLC
Delaware Innovation Space (DISI)
Wilmington, Delaware